Alert: Major Price Decline (12/8/23)-Lifecore Biomedical Inc (NASDAQ: LFCR).


Lifecore Biomedical Inc (NASDAQ: LFCR) stock closed at $6.27 on 12/8/23 after a major decline of -11.1%. However, this decline was accompanied by normal trading volume at 83% of normal. The stock has declined -12.6% during the last week but has been exceptionally strong relative to the market over the last nine months.


Current PriceTarget Research Rating

With future capital returns forecasted to be below the cost of capital, LFCR is expected to be a major Value Eraser.

Lifecore Biomedical is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.